HRID 39439als Produkt
1632006-28-0Cc1c(C(=O)Nc2ccc(S(C)(=O)=O)cc2)cn(CCO)c1-c1ccccc1C(F)(F)FNOSNHVJANRODGR-UHFFFAOYSA-NEsaxerenone is under investigation in clinical trial NCT02722265 (Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension).
VerwendenEsaxerenone, is a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
1632006-28-0DTXSID601336896CHEMBL2181932